Harrow- 8.625% NT REDEEM 30/04/2026 USD 25 Common Stock

As of the most recent data (June 2026), HROWL shows a common stock of $37K. That compares with $36K in the prior-year period — up 2.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HROWL's common stock is now $37K (was $36K) — a 2.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Harrow- 8.625% NT REDEEM 30/04/2026 USD 25 is outperforming or lagging.

Tracking HROWL's common stock over time shows whether Harrow- 8.625% NT REDEEM 30/04/2026 USD 25 is scaling, shrinking, or reshaping that part of the business. The current reading is $37K That compares with $36K in the prior-year period — up 2.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Harrow- 8.625% NT REDEEM 30/04/2026 USD 25's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $37K) with ownership activity and broader fundamentals.

Harrow- 8.625% NT REDEEM 30/04/2026 USD 25's common stock is $37K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.